Skip to content

Medical-device intelligence

Hmd Biomedical, Inc.: FDA clearances and recalls

Research Hmd Biomedical, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

10 clearance records and 0 recall records in the covered releases, across 1 source company names and 2 product codes. Dated history runs from Aug 4, 2003 to Aug 29, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

10 matching records
Device / recordCompany in FDA recordSourceSource date
GlucoLeader Enhance 2 Blood Glucose Monitoring SystemK212248 · NBWHmd Biomedical, Inc.510(k)Aug 29, 2022FDA decision date
GlucoLeader Enhance Blood Glucose Monitoring SystemK182428 · NBWHmd Biomedical, Inc.510(k)May 8, 2019FDA decision date
Goodlife AC-300 Blood Glucose Monitoring System, Goodlife AC-301 Blood Glucose Monitoring System, Goodlife AC-302 Blood Glucose Monitoring System…K140150 · NBWHmd Biomedical, Inc.510(k)May 14, 2015FDA decision date
FIA Blood Glucose Monitoring System (G2)K131173 · NBWHmd Biomedical, Inc.510(k)Sep 18, 2014FDA decision date
GOODLIFE CS-200 (SINGLE PATIENT USE), CS-200 PROFESSIONAL (MULTIPLE PATIENT USE) BLOOD GLUCOSE MONITORING SYSTEMSK121433 · LFRHmd Biomedical, Inc.510(k)Feb 14, 2013FDA decision date
PRECICHEK NS-101 POCT PROFESSIONAL BLOOD GLUCOSE MONITORING SYSTEMK113314 · LFRHmd Biomedical, Inc.510(k)Nov 9, 2012FDA decision date
TEST, BLOOD GLUCOSE SYSTEMK120064 · NBWHmd Biomedical, Inc.510(k)Sep 5, 2012FDA decision date
GL GOODLIFE SERIES BLOOD GLUCOSE MONITORING SYSMTEMK113307 · LFRHmd Biomedical, Inc.510(k)Jul 27, 2012FDA decision date
GLUCOLEADER ENHANCE SELF-MONITORING OF BLOOD GLUCOSE SYSTEMK032985 · NBWHmd Biomedical, Inc.510(k)Oct 21, 2003FDA decision date
GLUCOLEADER VALUEK023279 · NBWHmd Biomedical, Inc.510(k)Aug 4, 2003FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗